SCHEMBL5037193

SCHEMBL5037193

CC(C)CC(N)[PH](=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5072971 0.77
Phosphonic Acid SCHEMBL7866708 0.74 RNPEP (0.39)
Phosphonic Acid SCHEMBL9705797 0.74 RNPEP (0.39)
SCHEMBL1890480 0.72
SCHEMBL579981 0.70
SCHEMBL9329975 0.69 SLC7A5 (0.48)
SCHEMBL9329977 0.69 SLC7A5 (0.48)
SCHEMBL8860012 0.69
Leucine SCHEMBL1191429 0.69 SLC7A5 (0.82)
Leucine SCHEMBL1191424 0.69 SLC7A5 (0.82)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150125406-A1 TOPICAL SKIN CARE COMPOSITION JAFER LIMITED (VG) 2015-05-07 US claimed
EP-0897717-B1 Whitening skin cosmetic composition and melanogenic inhibitor agent containing such cosmetic composition EXSYMOL SA (MC) 2004-06-09 EP claimed
US-6280715-B1 APPLYING AMINOORGANOPHOSPHONIC ACID OR -PHOSPHINIC ACID DERIVATIVE AND ORGANOSILICON COMPOUND EXSYMOL S.A.M. (MC) 2001-08-28 US claimed
JP-11092334-A None JP disclosed
US-20150125406-A1 TOPICAL SKIN CARE COMPOSITION JAFER LIMITED (VG) 2015-05-07 US disclosed
US-7345082-B2 Phosphinic acids HOFFMANN-LA ROCHE INC. (US) 2008-03-18 US disclosed
EP-1685142-B1 PHOSPHINIC ACID DERIVATIVES, BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE HOFFMANN LA ROCHE (CH) 2008-01-09 EP disclosed
EP-1685142-A1 PHOSPHINIC ACID DERIVATIVES, BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2006-08-02 EP disclosed
WO-2005044830-A1 PHOSPHINIC ACIDS DERIVATIVES, BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2005-05-19 WO disclosed
US-20050107341-A1 Phosphinic acids F. HOFFMANN-LA ROCHE AG (CH) 2005-05-19 US disclosed
US-6737416-B2 THROMBOLYTIC AGENT HAVING HIGHER SAFETY MEIJI SEIKA KAISHA LTD. (JP) 2004-05-18 US disclosed
US-20030119787-A1 Phosphonic acid derivative having inhibitory activity against carboxypeptidase B MEIJI SEIKA KAISHA LTD. (JP) 2003-06-26 US disclosed
US-6576627-B1 Such as 7-amino-2-((2-methyl-1-(3-phenylpropanoylamino)-propyl)hydroxyphosphinoyl) -methylheptanoic acid; thrombotic disease MEIJI SEIKA KAISHA LTD. (JP) 2003-06-10 US disclosed
EP-1152004-B1 Phosphonic acid derivatives having carboxypeptidase B inhibitory action MEIJI SEIKA KAISHA (JP) 2003-05-07 EP disclosed
EP-1174434-A1 Phosphonic acid derivative having inhibitory activity against carboxypeptidase B MEIJI SEIKA KAISHA LTD. (JP) 2002-01-23 EP disclosed
EP-1152004-A1 PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITORY ACTIVITY MEIJI SEIKA KAISHA LTD. (JP) 2001-11-07 EP disclosed
US-6280715-B1 APPLYING AMINOORGANOPHOSPHONIC ACID OR -PHOSPHINIC ACID DERIVATIVE AND ORGANOSILICON COMPOUND EXSYMOL S.A.M. (MC) 2001-08-28 US disclosed
JP-H1192334-A COSMETIC COMPOSITION ESPECIALLY USEFUL FOR WHITENING OF SKIN AND MELANOGENESIS-SUPPRESSING AGENT CONTAINING THE SAME COSMETIC COMPOSITION EXSYMOL SAM 1999-04-06 JP disclosed
WO-1997009333-A1 NOVEL THIO-PHOSPHOORGANIC COMPOUNDS WITH PLANT PROTECTING ACTIVITY SITRA FOUNDATION (FI) 1997-03-13 WO disclosed